Apicore US LLC
USPTO PatentsView assignee record - 16 granted patents across 7 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07C (Acyclic OR Carbocyclic Compounds).
The verdict
According to USPTO PatentsView, Apicore ranks #17,443 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 7 technology areas.
- #17,443
- of 49,997 US assignees by volume
- 21st percentile
- by Innovation Score (26.6/100)
- 12.4
- avg claims per patent
- -67%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R17443 · US Corporation #17,443 · 16 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 16 grants
- MID-PACK #17,443/49,997
- PHOTO-FINISH Anaren
- CPC-NARROW C07C · 7 areas
- INNOV-THIN 26.6/100
- CLAIMS-RICH 12.4 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -67% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Anaren, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Apicore’s 26.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Apicore
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Apicore US · this assignee 27
Apicore US · this assignee
27 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Apicore's Innovation Score is 26.6/100 (21st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Apicore?
Each dot is one of Apicore’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Apicore’s own 12.4 claims/patent is at or below the 13.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Apicore's grants concentrate
Apicore US LLC is a focused PatentsView assignee: 7 CPC subclasses with 56.3% of grants classified under C07C (Acyclic OR Carbocyclic Compounds). Peak complete grant year is 2019 (6 grants) versus a trough of 1 in 2017. By volume, Apicore sits between Anaren, Inc. and Arriver Software AB.
Who files at Apicore's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Anaren
Anaren, Inc.
16 patents
- Andon Health
Andon Health Co., Ltd.
16 patents
- Angiomed & Medizi…
Angiomed GmbH & Co. Medizintechnik KG
16 patents
- Angion Biomedica
Angion Biomedica Corp.
16 patents
- Aqua-aerobic Syst…
Aqua-Aerobic Systems, Inc.
16 patents
- Aquabeam
AquaBeam, LLC
16 patents
- Ardea Biosciences
Ardea Biosciences, Inc
16 patents
- Arriver Software…
Arriver Software AB
16 patents
- Apicore US ◀
Apicore US LLC
16 patents
What this shows Apicore holds 16 patents at rank #17,457, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Apicore
By rank, the assignees closest to #17,457 in granted patent volume.
- Anaren, Inc. #17,453 · 16 patents
- Andon Health Co., Ltd. #17,454 · 16 patents
- Angiomed GmbH & Co. Medizintechnik KG #17,455 · 16 patents
- Angion Biomedica Corp. #17,456 · 16 patents
- Aqua-Aerobic Systems, Inc. #17,458 · 16 patents
- AquaBeam, LLC #17,459 · 16 patents
- Ardea Biosciences, Inc #17,460 · 16 patents
- Arriver Software AB #17,461 · 16 patents
Leaders in C07C (Acyclic OR Carbocyclic Compounds)
Other assignees with the most granted patents in Apicore's primary technology class.
Apicore's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
27 21st percentile higher than 21% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 12.5% |
| 2016 | 2 | 12.5% |
| 2017 | 1 | 6.3% |
| 2018 | 1 | 6.3% |
| 2019 | 6 | 37.5% |
| 2020 | 3 | 18.8% |
| 2021 | 1 | 6.3% |
Which technologies does Apicore US LLC patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Apicore US LLC's patent record in context - here's where to go next.
- Apicore US LLC's lead technology class is C07C (Acyclic OR Carbocyclic Compounds), 56.3% of its portfolio - see every assignee active in that class. Explore C07C
- Ranked #17,443 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Apicore US LLC against Anaren, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 26.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.